The Latest Breaking News from Lyme Disease

Valneva SE (NASDAQ: VALN) shares are trading higher after the company and Pfizer announced they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License Agreement for Lyme disease vaccine candidate VLA15.

Valneva stock rocketed Tuesday on a $95 million investment from Pfizer, its Lyme disease vaccine partner. Pfizer will get an 8.1% stake.

The bacterial infection can cause heart and nerve problems

Climate change is responsible for additional ticks, which dramatically increases the risk of Lyme disease.

The number of Lyme disease cases have increased - particularly in the South West - in recent years, sparking a warning to dog owners who exercise their pets in the countryside

Mum-of-three Pauline Bowie, 54, suffered brain fog, headaches, muscle pain, carpal tunnel, and was even wetting herself after being bitten by a tick in America in 1989.

Ticks have a thing for Mary Ritter, but the sentiment is unrequited.

Valneva SE (NASDAQ:VALN) and Pfizer Inc (NYSE:PFE) have reported Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15.  In pediatric participants (5-17 years old) who received VLA15 in either the two-dose schedule (N=93) or three-dose schedule (N=97), VLA15 was found to be more immunogenic than in adults with both vaccination schedules tested.  These…

Lyme Disease UK has issued a warning to walkers after they say that people who do this exercise are at a higher risk of developing the potentially painful disease